Share

UnitedHealth Has a High-Class Problem

(UNH) on Thursday reported third-quarter net income of $1.6 billion.

Advertisement

After $1.64 actual earnings per share reported by UnitedHealth Group Inc for the previous quarter, Wall Street now forecasts -0.61% negative EPS growth.

Tesla Motors, Inc. (TSLA) of the Consumer Goods sector is down -0.11% trading at a volume of 327899 shares.

Optum’s total revenue for the third quarter of 2015 ballooned to $19.3 billion, primarily due to the addition of pharmacy benefits accounts acquired in UnitedHealth’s recently completed $12.8 billion purchase of Catamaran Corp. The company’s 50 day moving average price is $117.68 and its 200 day moving average price is $118.99. That compared to consensus estimates from Thomson Reuters of $1.64 in EPS on revenue of $40.17 billion. Yet the shares dipped as the company’s net profit margin of 3.8% fell 1.1 percentage points from a year earlier…

Revenue increased to $41.5 billion from $32.8 billion past year.

UnitedHealth Group (UNH) is a diversified health and well-being company dedicated to assisting people live healthier lives and assisting to make the health system work better for everyone. Earnings grew 1.2% year over year.

In other UnitedHealth Group news, Director Richard T. Burke sold 50,000 shares of UnitedHealth Group stock in a transaction that occurred on Friday, September 11th.

The stock closed down 1.6 percent on Wednesday at $122.07. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Citigroup initiated the stock on October 2 with “Buy” rating.

Shares of UnitedHealth, up 21% this year, ticked up 1.2% in light premarket trading.

Out of 4 analysts covering UnitedHealth Group (NYSE:UNH), 4 rate it “Buy”, 0 “Sell”, while 0 “Hold”. Finally, Oppenheimer raised their price target on shares of UnitedHealth Group from $133.00 to $140.00 and gave the stock an “outperform” rating in a report on Friday, July 17th. 15 analysts rated the company as a strong buy. UnitedHealth Group now has an average rating of “Buy” and a consensus target price of $138.39. UnitedHealthcare, the company’s prominent health insurance division, posted a lower operating margin year over year. The Company’s business platforms include UnitedHealthcare and Optum.

Advertisement

While UnitedHealth is investing in its Optum segment, key rivals like Aetna Inc. and the Blue Cross-Blue Shield insurer Anthem Inc. are digesting multi-billion-dollar acquisitions of other health insurers. OptumHealth is a health and wellness company serving the psychological physical and financial needs of individuals.

Unh Healthcare Lane